Glass House Brands Inc

Glass House Brands Inc (GLAS) Stock Analysis

$3.190

-0.447 (-14.02%)At close

Loading chart…
High
3.835
Open
3.740
VWAP
3.38
Volume
2.03M
Mkt Cap
—
Low
3.100
Amount
6.86M
EV/EBITDA, TTM
-1,764.30

Glass House Brands Inc. is a vertically integrated cannabis company. The Company, through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and cannabis-related consumer packaged goods (CPG) to third-party retail stores in the state of California. The Company also owns and operates retail cannabis stores in the state of California. The Company operates in three reportable segments: retail, wholesale biomass and cannabis-related consumer packaged goods (CPG). The Company operates multiple greenhouse cultivation facilities located in Carpinteria and Camarillo, California, and its manufacturing production facility is located in Lompoc, California. Its portfolio of brands includes Glass House Farms, PLUS, REEFORM, Allswell, and Mama Sue Wellness. Its retail landscape consists of approximately 10 stores positioned across California, including the pottery, farmacy, and natural healing center (NHC).

AI analysis of Glass House Brands Inc (GLAS)

Sell

Given the current price of $3.19, the stock has seen a significant decline of 74.68% year-to-date. The RSI is extremely low at 3.639, indicating oversold conditions, but the forward P/E ratio is high at 31.4465, suggesting that the stock may be overvalued relative to its earnings potential. The gross margin has also dropped to 26.22%, down from 46.81% in the previous year, highlighting deteriorating profitability. While there is potential for recovery, the risks associated with persistent net losses and high reliance on external capital make this a sell for now.

Valuation Metrics

The current forward P/E ratio for Glass House Brands Inc (GLAS) is 31.45, compared to its 5-year average forward P/E of 168.99.

Forward P/E

Undervalued
5Y Average P/E
168.99
Current P/E
31.45
Overvalued
281.81
Undervalued
56.18

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-2219.85
Current EV/EBITDA
-1764.30
Overvalued
440.31
Undervalued
-4880.01

Forward P/S

Strongly Undervalued
5Y Average P/S
3.13
Current P/S
1.39
Overvalued
3.82
Undervalued
2.44

Events Timeline

2026-10-14 (ET)

08:00:00

Glass House Achieves GACP Certification, Aiming for Medical Cannabis Exports

2026-09-29 (ET)

08:00:00

Glass House Brands CFO Mark Vendetti Plans Retirement

2026-08-13 (ET)

17:00:00

Company Reports Q2 Adjusted EBITDA of $5.7M

2026-07-07 (ET)

09:30:00

GlassHouse Completes First International CBD Sale to Europe

News

GLAS FAQ — answered by Alphio AI

Glass House Brands Inc. is a vertically integrated cannabis company. The Company, through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and cannabis-related consumer packaged goods (CPG) to third-party retail stores in the state of California. The Company also owns and operates retail cannabis stores in the state of California. The Company operates in three reportable segments: retail, wholesale biomass and cannabis-related consumer packaged goods (CPG). The Company operates multiple greenhouse cultivation facilities located in Carpinteria and Camarillo, California, and its manufacturing production facility is located in Lompoc, California. Its portfolio of brands includes Glass House Farms, PLUS, REEFORM, Allswell, and Mama Sue Wellness. Its retail landscape consists of approximately 10 stores positioned across California, including the pottery, farmacy, and natural healing center (NHC). It operates in the Consumer Non-Cyclicals sector.

Given the current price of $3.19, the stock has seen a significant decline of 74.68% year-to-date. The RSI is extremely low at 3.639, indicating oversold conditions, but the forward P/E ratio is high at 31.4465, suggesting that the stock may be overvalued relative to its earnings potential. The gross margin has also dropped to 26.22%, down from 46.81% in the previous year, highlighting deteriorating profitability. While there is potential for recovery, the risks associated with persistent net losses and high reliance on external capital make this a sell for now.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading